The U.S. Food and Drug Administration has approved a new over-the-counter medicine designed to reverse opioid overdoses.
The product, called Rextovy, is a naloxone nasal spray made by Amphastar Pharmaceuticals. Because it can now be sold without a prescription, people can buy it directly from pharmacies, convenience stores, and online stores.
The approval comes at a time when opioid overdoses continue to be a major public health problem in the United States. Opioids are a group of drugs that include prescription pain medicines such as oxycodone and morphine, as well as illegal drugs such as heroin and illegally made fentanyl.
These substances affect the brain and can relieve pain, but they can also slow breathing. In an overdose, a person’s breathing can become dangerously slow or even stop completely, which can lead to brain injury or death within minutes.
Naloxone is a medicine that can quickly reverse the effects of an opioid overdose. It works by attaching to the same areas in the brain that opioids target.
In doing so, it blocks the effects of the opioid and helps restore normal breathing. Naloxone does not produce a “high” and is considered safe even if it turns out that opioids are not the cause of the emergency.
Rextovy contains 4 milligrams of naloxone hydrochloride and is given as a spray into the nose. The product packaging includes simple picture instructions that guide users through five steps.
One of the most important steps is calling emergency services after giving the first dose. Even if the person wakes up and seems to recover, medical care is still needed because the effects of some opioids can last longer than naloxone.
When people regain consciousness after an overdose reversal, they may experience symptoms such as shaking, sweating, nausea, confusion, or irritability.
These reactions happen because the body suddenly loses the effects of the opioid and may begin experiencing withdrawal symptoms. Although these symptoms can be unpleasant, they are generally less dangerous than the overdose itself.
The FDA says reducing opioid overdose deaths remains one of its top priorities. Health officials believe that making naloxone products easier to obtain can save lives because overdoses often happen at home or in places where medical professionals are not immediately available.
Family members, friends, co-workers, and even strangers may become the first people able to provide help.
Public health experts have increasingly encouraged people who may come into contact with someone at risk of overdose to keep naloxone nearby. Many schools, libraries, community organizations, and workplaces have also started stocking naloxone products as emergency supplies.
The approval of another nonprescription naloxone spray gives consumers more choices and may improve access in communities that need these products. However, naloxone is not a solution to opioid addiction itself. Long-term progress will also require better prevention programs, addiction treatment services, and education about the dangers of opioid misuse.
The FDA’s decision is important because it lowers barriers to obtaining a medication that can mean the difference between life and death. The availability of another easy-to-use nasal spray may allow more people without medical training to respond quickly during an emergency and potentially save lives.
If you care about pain, please read studies about how to manage gout with a low-purine diet, and a guide to eating right for arthritis.
For more health information, please see recent studies about the link between processed foods and chronic diseases, and avoid these 8 foods to ease arthritis pain.
Source: U.S. Food and Drug Administration.
